Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases

Publisher： Karger

E-ISSN： 1662-6575|9|1|76-82

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.1, 2016-01, pp. : 76-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radioembolization with Yttrium-90 Microspheres (SIRT) in Pancreatic Cancer Patients with Liver Metastases: Efficacy, Safety and Prognostic Factors

By  

Oncology, Vol. 86, Iss. 1, 2013-12 ,pp. : 24-32

Karger

Access to resources Recommend Favorite

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-07 ,pp. : 627-633

Karger

Access to resources Recommend Favorite

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 479-486

Karger

Access to resources Recommend Favorite

Corrigendum: Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres (2008 Phys. Med. Biol. 53 6591–603)

By Flamen Patrick   Vanderlinden Bruno   Delatte Philippe   Ghanem Ghanem   Ameye Lieveke     Hendlisz Alain  

Physics in Medicine and Biology, Vol. 59, Iss. 10, 2014-05 ,pp. : 2549-2551

IOP Publishing

Access to resources Recommend Favorite

Towards new response criteria in neuroendocrine tumors: Which changes in MRI parameters are associated with longer progression‐free survival after radioembolization of liver metastases?

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 41, Iss. 2, 2015-02 ,pp. : 361-368

John Wiley & Sons Inc

Access to resources Recommend Favorite